Showing results (41-50 of 516) with videos related to
Sort By:
Pageof 52
Anticancer Research|March 1, 1993
Phase II-study for treatment of refractory acute leukemia with intermediate-dose cytosine arabinoside and amsacrineU Jehn, V HeinemannAnnals of Hematology|March 1, 1993
Phase-II study of treatment of refractory acute leukemia with intermediate-dose cytosine arabinoside and amsacrineU Jehn, V HeinemannAnticancer Research|March 1, 1991
New drugs in the treatment of acute and chronic leukemia with some emphasis on m-AMSAU Jehn, V HeinemannHaematology and Blood Transfusion|January 1, 1990
Intermediate-dose Ara-C/m-AMSA for remission induction and high-dose Ara-C/m-AMSA for intensive consolidation in relapsed and refractory adult acute myelogeneous leukemiaU Jehn, V HeinemannAnnals of Hematology|October 1, 1991
Acute myeloid leukemia in the elderly: biological features and search for adequate treatmentV Heinemann, U JehnCancer Detection and Prevention|June 9, 1998
Successful treatment of accelerated and blastic phase of chronic myeloid leukemia with high-dose interferon-alpha combined with hydroxyureaU Jehn, V HeinemannLaboratory Investigation; a Journal of Technical Methods and Pathology|January 1, 2000
Induction of inducible nitric oxide synthase is an essential part of tumor necrosis factor-alpha-induced apoptosis in MCF-7 and other epithelial tumor cellsC Binder, M Schulz, W Hiddemann, et al.Biotechniques|December 1, 1995
Short technical reports. Quantification of ribozyme-mediated RNA cleavage using silver-stained polyacrylamide gelsK Palfner, M Kneba, W Hiddemann, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1995
The effect of stem-cell factor, interleukin-3 and erythropoietin on in vitro erythropoiesis in myelodysplastic syndromesW Verbeek, K Vehmeyer, B Wörmann, et al.Journal of Internal Medicine. Supplement|January 1, 1997
Treatment of follicular follicle centre lymphomas: current status and future perspectivesW Hiddemann, M Unterhalt, C Buske, et al.Pageof 52